Celine-Lea Halioua-Haubold
Overview
Explore the profile of Celine-Lea Halioua-Haubold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McKenzie B, Peloquin M, Graves J, Chen F, Tovar A, Carttar T, et al.
Sci Rep
. 2025 Feb;
15(1):5380.
PMID: 39948141
Declining metabolic function with aging is a conserved phenotype across many species. While aging-associated changes in metabolic status have been investigated rigorously in humans, less is known about metabolic aging...
2.
Peloquin M, Tovar A, Graves J, Stefanovski D, Tucker K, Marietti E, et al.
Sci Rep
. 2024 Jun;
14(1):12639.
PMID: 38825593
Chronic feeding of a high fat diet (HFD) in preclinical species induces broad metabolic dysfunction characterized by body weight gain, hyperinsulinemia, dyslipidemia and impaired insulin sensitivity. The plasma lipidome is...
3.
McKenzie B, Peloquin M, Tovar A, Graves J, Ratcliff E, Tucker K, et al.
Am J Vet Res
. 2024 Apr;
85(6).
PMID: 38604223
Objective: The goal of this study was to characterize changes induced by a high-fat diet in body composition, insulin levels and sensitivity, blood lipids, and other key biomarkers also associated...
4.
Halioua-Haubold C, Jolly J, Smith J, Pinedo-Villanueva R, Brindley D, MacLaren R
Eye (Lond)
. 2019 Jul;
33(8):1215-1223.
PMID: 31312000
Background: The first gene therapy for an inherited retinal dystrophy recently received market approval in the United States; multiple other gene therapies are in the clinical pipeline. Thus far, gene...
5.
Lam C, Meinert E, Halioua-Haubold C, Carter A, Yang A, Brindley D, et al.
BMJ Open
. 2019 Jul;
9(7):e026172.
PMID: 31278092
Introduction: Following recent regulatory approvals of two chimeric antigen receptor T-cell (CAR-T) therapies, the field now faces a number of post-approval challenges. These challenges are in some respects defined and,...
6.
Meinert E, Alturkistani A, Osama T, Halioua-Haubold C, Car J, Majeed A, et al.
JMIR Res Protoc
. 2019 Feb;
8(2):e10705.
PMID: 30730295
Background: Pharmacogenomics suggests that diseases with similar symptomatic presentations often have varying genetic causes, affecting an individual patient's response to a specific therapeutic strategy. Gene therapies and somatic cell therapies...
7.
Halioua-Haubold C, Peyer J, Smith J, Arshad Z, Scholz M, Brindley D, et al.
Yale J Biol Med
. 2017 Dec;
90(4):683-693.
PMID: 29259533
Developers of gene therapy products (GTPs) must adhere to additional regulation beyond that of traditional small-molecule therapeutics, due to the unique mechanism-of-action of GTPs and the subsequent novel risks arisen....
8.
Arshad Z, Halioua-Haubold C, Roberts M, Urso-Baiarda F, Branford O, Brindley D, et al.
Aesthet Surg J
. 2017 Jun;
38(2):199-210.
PMID: 28591768
Background: Adipose tissue, which can be readily harvested via a number of liposuction techniques, offers an easily accessible and abundant source of adipose-derived stem cells (ASCs). Consequently, ASCs have become...